Dr Lalchandani Labs IPO vs E2E Networks IPO

Comparison between Dr Lalchandani Labs IPO and E2E Networks IPO.

IPO Details

Dr Lalchandani Labs IPO is a SME Fixed Price IPO proposed to list at BSE SME while E2E Networks IPO is a SME Fixed Price proposed to list at NSE SME.

Issue Size and Price

The total issue size of Dr Lalchandani Labs IPO is up to ₹3.98 Cr whereas the issue size of the E2E Networks IPO is up to ₹20.88 Cr. The final issue price of Dr Lalchandani Labs IPO is ₹30.00 per share and of E2E Networks IPO is ₹57.00 per share.

 Dr Lalchandani Labs IPOE2E Networks IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹30.00 per share₹57.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size4000 shares2000 shares
Fresh Issue Size13,28,000 shares25,56,000 shares
Fresh Issue Size (Amount)up to ₹3.98 Crup to ₹14.57 Cr
OFS Issue Size0 shares11,08,000 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹6.32 Cr
Issue Size Total13,28,000 shares36,64,000 shares
Issue Size Total (Amount)up to ₹3.98 Crup to ₹20.88 Cr

IPO Timetable

Dr Lalchandani Labs IPO opens on Apr 25, 2018, while E2E Networks IPO opens on May 03, 2018. The closing date of Dr Lalchandani Labs IPO and E2E Networks IPO is Apr 27, 2018, and May 07, 2018, respectively.

 Dr Lalchandani Labs IPOE2E Networks IPO
Issue OpenApr 25, 2018May 03, 2018
Issue CloseApr 27, 2018May 07, 2018
Basis Of Allotment (Tentative)May 10, 2018
Listing date (Tentative)May 09, 2018May 15, 2018

Financials & KPIs

Dr Lalchandani Labs IPO P/E ratio is , as compared to E2E Networks IPO P/E ratio of .

 Dr Lalchandani Labs IPOE2E Networks IPO
Financials

Company Financials (Restated)

Period Ended31 Jan 201831 Mar 201731 Mar 201631 Mar 2015
Assets6.033.763.661.87
Total Income2.054.623.031.93
Profit After Tax0.240.710.320.32
NET Worth3.270.920.870.40
Reserves and Surplus0.37
Total Borrowing1.511.771.550.68
Amount in ₹ Crore

Company Financials (Restated)

Period Ended31 Dec 201731 Mar 201731 Mar 201631 Mar 2015
Assets22.9815.7213.637.96
Total Income27.2129.5321.479.93
Profit After Tax5.264.212.220.84
NET Worth16.2310.976.754.53
Reserves and Surplus15.8610.606.384.16
Total Borrowing1.512.571.83
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)89.80%67.51%
Promoter Shareholding (Post-Issue)60.78%54.47%
Market Cap₹13.00 Cr.₹81.20 Cr.

Shares Offered

In the Dr Lalchandani Labs IPO Retail Individual Investors (RII) are offered 6,64,000 shares while in E2E Networks IPO retail investors are offered 6,64,000 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Dr Lalchandani Labs IPO and 0 shares in E2E Networks IPO.

 Dr Lalchandani Labs IPOE2E Networks IPO
Anchor Investor Reservation0 shares0 shares
Market Maker Reservation72,000 shares1,94,000 shares
QIB0 shares0 shares
NII6,64,000 shares18,32,000 shares
RII6,64,000 shares18,32,000 shares
Employee0 shares0 shares
Total13,28,000 shares36,64,000 shares

Bids Received (Subscription)

Dr Lalchandani Labs IPO subscribed 4.63x in total, whereas E2E Networks IPO subscribed 72.11x.

 Dr Lalchandani Labs IPOE2E Networks IPO
NII (times)3.13x130.82x
RII (times)6.13x13.39x
Total (times)4.63x72.11x

Compare with others

Compare:

Dr Lalchandani Labs IPO Vs E2E Networks IPO